Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Bland

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Developmental Cell|February 6, 2007
Micromanaging alternative splicing during muscle differentiationChristopher S Bland, Thomas A Cooper
Cancer Treatment Reviews|November 30, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancerJason A Efstathiou, Alicia K Morgans, Christopher S Bland, et al.
Applied and Environmental Microbiology|October 6, 2005
Mycobacterial ecology of the Rio GrandeChristopher S Bland, Jamie M Ireland, Eduardo Lozano, et al.
Advances in Therapy|June 24, 2026
Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate CancerStephen J Freedland, Amanda Ribbands, Maëlys Touya, et al.
Advances in Therapy|June 1, 2026
Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate CancerStephen J Freedland, Amanda Ribbands, David Russell, et al.
European Urology Focus|June 14, 2024
Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in OncologyArnulf Stenzl, Andrew J Armstrong, Andrea Sboner, et al.
Molecular Cell|August 5, 2014
Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesisRavi K Singh, Zheng Xia, Christopher S Bland, et al.
Nucleic Acids Research|July 17, 2010
Global regulation of alternative splicing during myogenic differentiationChristopher S Bland, Eric T Wang, Anthony Vu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2011
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivoKristen L Meerbrey, Guang Hu, Jessica D Kessler, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Developmental Cell|February 6, 2007
Micromanaging alternative splicing during muscle differentiationChristopher S Bland, Thomas A Cooper
Cancer Treatment Reviews|November 30, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancerJason A Efstathiou, Alicia K Morgans, Christopher S Bland, et al.
Applied and Environmental Microbiology|October 6, 2005
Mycobacterial ecology of the Rio GrandeChristopher S Bland, Jamie M Ireland, Eduardo Lozano, et al.
Advances in Therapy|June 24, 2026
Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate CancerStephen J Freedland, Amanda Ribbands, Maëlys Touya, et al.
Advances in Therapy|June 1, 2026
Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate CancerStephen J Freedland, Amanda Ribbands, David Russell, et al.
European Urology Focus|June 14, 2024
Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in OncologyArnulf Stenzl, Andrew J Armstrong, Andrea Sboner, et al.
Molecular Cell|August 5, 2014
Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesisRavi K Singh, Zheng Xia, Christopher S Bland, et al.
Nucleic Acids Research|July 17, 2010
Global regulation of alternative splicing during myogenic differentiationChristopher S Bland, Eric T Wang, Anthony Vu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2011
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivoKristen L Meerbrey, Guang Hu, Jessica D Kessler, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Pageof 1